UNASSIGNED: This randomised controlled trial included participants two weeks before discharge from subacute rehabilitation. All participants received usual treatment. The intervention entailed an add-on of six to eight self-management sessions lasting 45-60 min within a period of nine months after discharge. This novel neuro-rehabilitation intervention focused on promoting growth, development and self-efficacy by facilitating the participants\' self-management strategies regarding their activities and social network. All participants were assessed at baseline, three months and nine months after discharge. The primary outcome was self-efficacy measured by the Stroke Self-Efficacy Questionnaire.
UNASSIGNED: Sixty-nine individuals with stroke aged > 65 years were randomised. Their mean(SD) age was 76(6) years; 32 (46%) were female. No significant difference was found between the groups at baseline. Improvement recorded in the intervention group did not significantly differ from that of the control group with regard to primary outcome or secondary outcomes.
UNASSIGNED: This novel self-management intervention had no significant effect measured by the primary outcome self-efficacy or quality of life. Furthermore, no impact was observed on participation and autonomy compared with usual treatment.Clinical trial registration-URL: ClinicalTrials.gov, NCT03183960. Registered on 12 June 2017.
The present study testing a novel self-management neuro-rehabilitation intervention for people with stroke aged more than 65 years failed to improve self-efficacy, quality of life, and impact on participation and autonomy.Post hoc analyzes showed a lower caregiver burden at three and nine months in the intervention group as compared to the control group.The approach of perceiving the stroke individual and the informal caregiver as one unit (dyad), involving both in decisions regarding everyday activities and roles in everyday life especially within their shared part of life, appears important and warrants further development.
■这项随机对照试验包括亚急性康复出院前两周的参与者。所有参与者都接受了常规治疗。干预措施需要在出院后的9个月内增加6到8次自我管理课程,持续45-60分钟。这种新颖的神经康复干预专注于促进生长,通过促进参与者关于他们的活动和社交网络的自我管理策略来发展和自我效能。所有参与者在基线时进行评估,出院后三个月和九个月。主要结局是通过卒中自我效能问卷测量的自我效能。
■69名年龄>65岁的中风患者被随机分组。他们的平均年龄(SD)为76(6)岁;32(46%)为女性。在基线时,组间没有发现显著差异。在主要结局或次要结局方面,干预组的改善与对照组没有显着差异。
■这种新颖的自我管理干预措施对主要结果自我效能或生活质量没有显着影响。此外,与常规治疗相比,未观察到对参与和自主性的影响.临床试验注册网址:ClinicalTrials.gov,NCT03183960。2017年6月12日注册
本研究对65岁以上的中风患者进行了一种新的自我管理神经康复干预,未能提高自我效能。生活质量,以及对参与和自治的影响。事后分析显示,与对照组相比,干预组3个月和9个月的护理人员负担较低。将中风个体和非正式护理人员视为一个单位(二元)的方法,涉及关于日常生活中的日常活动和角色的决策,特别是在他们共同的生活部分中,显得很重要,值得进一步发展。